Mission and Vision

The CEO Initiative represents an acceptance of the invitation from public authorities, domestically and internationally, to the private sector to forge robust public- private partnerships to stop Alzheimer's disease and dementia. Our vision is that the CEO Initiative becomes the leading business voice on this seminal public health issue of our time, which will have profound impact in fiscal, social and political matters as we “change the game” on Alzheimer’s.

By working together and in partnership with leading non-governmental organizations and governments, the CEO Initiative will identify and pursue research, therapy development, financing, and public awareness projects of the highest priority that, when achieved, can transform the global fight to stop Alzheimer’s disease. The CEO Initiative will:

  • Spur innovation and facilitate opportunities to improve the care of those affected by Alzheimer’s;
  • Reduce the time, cost and risk of drug development to improve the productivity of R&D investments;
  • Accelerate a means of prevention and treatment of Alzheimer’s, including improving the ability to identify and diagnose the disease,
  • Spur new models for care, care preparation and care delivery; and
  • Re-shape the environment in which society addresses Alzheimer’s patients and caregivers.

CEOi defines its work by focusing on five priorities and working across the private and public sectors to foster collaboration and success. Read more about these priorities here.